Sanofi SA
BMV:SNYN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
BMV:SNYN
|
FR |
|
F
|
Fresenius SE & Co KGaA
XMUN:FRE
|
DE |
|
Sanofi SA
OTC:SNYNF
|
FR |
|
S
|
Sanofi SA
DUS:SNW
|
FR |
|
M
|
Microsoft Corp
F:MSF
|
US |
Intrinsic Value
Is SNYN undervalued or overvalued?
See the intrinsic value estimate for 
Sanofi SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Sanofi Does
Sanofi is a global healthcare company that discovers, develops, makes, and sells prescription medicines and vaccines. Its main products cover areas like immunology, rare diseases, neurology, diabetes, and infectious diseases, along with preventive vaccines used by doctors, hospitals, public health systems, and pharmacies.
- Headquarters
- France FR
- Employees
- 74 846
- IPO date
- Jul 1, 2002
Sanofi has no economic moat
Patent protection keeps copies of some Sanofi medicines out, but it does not prevent rivals from developing alternative treatments. Competition against older medicines shows that these product-level protections do not provide a lasting shield across the company.
Read the full moat analysis
Earnings Waterfall
Sanofi SA
The intrinsic value for Sanofi SA (SNYN) under the Base Case is hidden MXN.
Compared with the current market price of 847.5 MXN, the stock appears hidden.
